Destruxins, cyclodepsipeptides, block the formation of actin rings and prominent clear zones and ruffled borders in osteoclasts

Bone

Volumn 33, Issue 3, 2003, Pages 443-455

  Nakagawa, H ^a   Takami, M ^b   Udagawa, N ^c   Sawae, Y ^b   Suda, K ^a   Sasaki, T ^b   Takahashi, N ^c   Wachi, M ^a   Nagai, K ^d   Woo, J T ^d  

^a TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

^b SHOWA UNIVERSITY   (Japan)

^c MATSUMOTO DENTAL UNIVERSITY   (Japan)

^d CHUBU UNIVERSITY   (Japan)

Author keywords

Actin ring; Bone resorption; Destruxin; Osteoclast; Ruffled border

Indexed keywords

ACTIN; CYCLODEPSIPEPTIDE; DESTRUXIN; DEXTRUXIN B; DEXTRUXIN E; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BONE METABOLISM; CELL DIFFERENTIATION; CELL POLARITY; CELL STRUCTURE; CELL SURVIVAL; CELL ULTRASTRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ELECTRON MICROSCOPY; ENTOMOPATHOGENY; MALE; MOUSE; MULTINUCLEAR CELL; NEWBORN; NONHUMAN; ORGAN CULTURE; OSTEOCLAST; OSTEOLYSIS;

EID: 10744222548     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(03)00201-1     Document Type: Article

References (43)

1. Suda T., Takahashi N., Martin T.J. Modulation of osteoclast differentiation. Endocr Rev. 13:1992;66-80.
2. Baron R. Molecular mechanisms of bone resorption by the osteoclast. Anat Rec. 224:1989;317-324.
3. Suda T., Nakamura I., Jimi E., Takahashi N. Regulation of osteoclast function. J Bone Miner Res. 12:1997;869-879.
4. Duong L.T., Lakkakorpi P., Nakamura I., Rodan G.A. Integrins and signaling in osteoclast function. Matrix Biol. 19:2000;97-105.
5. Rodan S.B., Rodan G.A. Integrin function in osteoclasts. J Endocrinol. 154:1997;S47-56.
6. +-ATPase type in the ruffled borders of osteoclasts. J Cell Biol. 111:1990;1305-1311.
7. +-ATPase B-subunit using isoform-specific antibodies. J Bone Miner Res. 12:1997;753-760.
8. Body J.J. Calcitonin for the long-term prevention and treatment of postmenopausal osteoporosis. Bone. 30:2002;75S-79S.
9. Holtrop M.E., Raisz L.G., Simmons H.A. The effects of parathyroid hormone, colchicine, and calcitonin on the ultrastructure and the activity of osteoclasts in organ culture. J Cell Biol. 60:1974;346-355.
10. Lerner U.H., Ransjo M., Klaushofer K., Horandner H., Hoffmann O., Czerwenka E., Koller K., Peterlik M. Comparison between the effects of forskolin and calcitonin on bone resorption and osteoclast morphology in vitro. Bone. 10:1989;377-387.
11. Suzuki H., Nakamura I., Takahashi N., Ikuhara T., Matsuzaki K., Isogai Y., Hori M., Suda T. Calcitonin-induced changes in the cytoskeleton are mediated by a signal pathway associated with protein kinase A in osteoclasts. Endocrinology. 137:1996;4685-4690.
12. Wada S., Udagawa N., Nagata N., Martin T.J., Findlay D.M. Physiological levels of calcitonin regulate the mouse osteoclast calcitonin receptor by a protein kinase Alpha-mediated mechanism. Endocrinology. 137:1996;312-320.
13. Takahashi S., Goldring S., Katz M., Hilsenbeck S., Williams R., Roodman G.D. Downregulation of calcitonin receptor mRNA expression by calcitonin during human osteoclast-like cell differentiation. J Clin Invest. 95:1995;167-171.
14. Kodaira Y. Toxic Substances to Insects, Produced by Aspergillus ochraceus and Oopsra destructor. Agr Biol Chem. 25:1961;261-262.
15. Ayer W.A., Pena-Rodriguez L.M. Metabolites produced by alternaria brassicae, the black spot pathogen of canola. Part 1, the phytotoxic components. J Nat Prod. 50:1987;400-407.
16. Akatsu T., Tamura T., Takahashi N., Udagawa N., Tanaka S., Sasaki T., Yamaguchi A., Nagata N., Suda T. Preparation and characterization of a mouse osteoclast-like multinucleated cell population. J Bone Miner Res. 7:1992;1297-1306.
17. Takami M., Woo J.T., Nagai K. Osteoblastic cells induce fusion and activation of osteoclasts through a mechanism independent of macrophage-colony-stimulating factor production. Cell Tissue Res. 298:1999;327-334.
18. Bradfisch G.A., Harmer S.L. omega-Conotoxin GVIA and nifedipine inhibit the depolarizing action of the fungal metabolite, destruxin B on muscle from the tobacco budworm (Heliothis virescens). Toxicon. 28:1990;1249-1254.
19. Pedras M.S., Zaharia I.L., Gai Y., Zhou Y., Ward D.E. In planta sequential hydroxylation and glycosylation of a fungal phytotoxin avoiding cell death and overcoming the fungal invader . Proc Natl Acad Sci USA. 98:2001;747-752.
20. Pedras M.S., Biesenthal C.J., Zaharia I.L. Comparison of the phytotoxic activity of the phytotoxin destruxin B and four natural analogs. Plant Sci. 156:2000;185-192.
21. Odier F., Vey A., Bureau J.P. In vitro effect of fungal cyclodepsipeptides on leukemic cells study of destruxins A, B and E . Biol Cell. 74:1992;267-271.
22. Morel E., Pais M., Turpin M., Guyot M. Cytotoxicity of cyclodepsipeptides on murine lymphocytes and on L 1210 leukemia cells. Biomed Pharmacother. 37:1983;184-185.
23. Chen H.C., Chou C.K., Sun C.M., Yeh S.F. Suppressive effects of destruxin B on hepatitis B virus surface antigen gene expression in human hepatoma cells. Antiviral Res. 34:1997;137-144.
24. Yeh S.F., Pan W., Ong G.T., Chiou A.J., Chuang C.C., Chiou S.H., Wu S.H. Study of structure-activity correlation in destruxins, a class of cyclodepsipeptides possessing suppressive effect on the generation of hepatitis B virus surface antigen in human hepatoma cells. Biochem Biophys Res Commun. 229:1996;65-72.
25. Sun C.M., Chen H.C., Yeh S.F. Suppressive effects of metabolites from Alternaria brassicaea on the hepatitis B surface antigen. Planta Med. 60:1994;87-88.
26. Nakamura I., Sasaki T., Tanaka S., Takahashi N., Jimi E., Kurokawa T., Kita Y., Ihara S., Suda T., Fukui Y. Phosphatidylinositol-3 kinase is involved in ruffled border formation in osteoclasts. J Cell Physiol. 172:1997;230-239.
27. Nakamura I., Takahashi N., Sasaki T., Tanaka S., Udagawa N., Murakami H., Kimura K., Kabuyama Y., Kurokawa T., Suda T., Fukui Y. Wortmannin, a specific inhibitor of phosphatidylinositol-3 kinase, blocks osteoclastic bone resorption. FEBS Lett. 361:1995;79-84.
28. Woo J.T., Kasai S., Stern P.H., Nagai K. Compactin suppresses bone resorption by inhibiting the fusion of prefusion osteoclasts and disrupting the actin ring in osteoclasts. J Bone Miner Res. 15:2000;650-662.
29. Zhang D., Udagawa N., Nakamura I., Murakami H., Saito S., Yamasaki K., Shibasaki Y., Morii N., Narumiya S., Takahashi N., Suda T. The small GTP-binding protein, rho p21, is involved in bone resorption by regulating cytoskeletal organization in osteoclasts. J Cell Sci. 108:1995;2285-2292.
30. Chellaiah M.A., Soga N., Swanson S., McAllister S., Alvarez U., Wang D., Dowdy S.F., Hruska K.A. Rho-A is critical for osteoclast podosome organization, motility, and bone resorption. J Biol Chem. 275:2000;11993-12002.
31. Dumas C., Matha V., Quiot J.M., Vey A. Effects of destruxins, cyclic depsipeptide mycotoxins, on calcium balance and phosphorylation of intracellular proteins in lepidopteran cell lines. Comp Biochem Physiol C. 114:1996;213-219.
32. +-translocating ATPase. Biochem Biophys Res Commun. 205:1994;1358-1365.
33. Bandani A.R., Amiri B., Butt T.M., Gordon-Weeks R. Effects of efrapeptin and destruxin, metabolites of entomogenous fungi, on the hydrolytic activity of a vacuolar type ATPase identified on the brush border membrane vesicles of Galleria mellonella midgut and on plant membrane bound hydrolytic enzymes. Biochim Biophys Acta. 1510:2001;367-377.
34. +-ATPase inhibitors on CTL-mediated cytotoxicity. Immunol Lett. 55:1997;139-144.
35. Naganuma S., Kuzuya N., Sakai K., Hasumi K., Endo A. Inhibition of the accumulation of lipid droplets in macrophage J774 by bafilomycin B1 and destruxin E. Biochim Biophys Acta. 1126:1992;41-48.
36. Cai P., Smith D., Katz B., Pearce C., Venables D., Houck D. Destruxin-A4 chlorohydrin, a novel destruxin from fungus OS-F68576 isolation, structure determination, and biological activity as an inducer of erythropoietin . J Nat Prod. 61:1998;290-293.
37. Tsunoo A., Kamijo M. Non-cyclic AMP-dependent, positive inotropic cyclodepsipeptides with negative chronotropy. J Pharmacol Exp Ther. 290:1999;1006-1012.
38. Sato M., Sardana M.K., Grasser W.A., Garsky V.M., Murray J.M., Gould R.J. Echistatin is a potent inhibitor of bone resorption in culture. J Cell Biol. 111:1990;1713-1723.
39. Dresner-Pollak R., Rosenblatt M. Blockade of osteoclast-mediated bone resorption through occupancy of the integrin receptor a potential approach to the therapy of osteoporosis . J Cell Biochem. 56:1994;323-330.
40. Yoneda T., Lowe C., Lee C.H., Gutierrez G., Niewolna M., Williams P.J., Izbicka E., Uehara Y., Mundy G.R. Herbimycin A, a pp60c-src tyrosine kinase inhibitor, inhibits osteoclastic bone resorption in vitro and hypercalcemia in vivo. J Clin Invest. 91:1993;2791-2795.
41. Hall T.J., Schaeublin M., Missbach M. Evidence that c-src is involved in the process of osteoclastic bone resorption. Biochem Biophys Res Commun. 199:1994;1237-1244.
42. Razzouk S., Lieberherr M., Cournot G. Rac-GTPase, osteoclast cytoskeleton and bone resorption. Eur J Cell Biol. 78:1999;249-255.
43. Coxon F.P., Helfrich M.H., Van't Hof R., Sebti S., Ralston S.H., Hamilton A., Rogers M.J. Protein geranylgeranylation is required for osteoclast formation, function, and survival inhibition by bisphosphonates and GGTI-298 . J Bone Miner Res. 15:2000;1467-1476.